Bovine hereditary cardiomyopathy: an animal model of human dilated cardiomyopathy

Bovine heriditary cardiomyopathy (bCMP) displays clinical characteristics of human idiopathic dilated cardiomyopathy (DCM). We studied isometric force of contraction in right ventricular trabeculae, plasma and tissue catecholamines, β- and α 1-adrenoceptor density, G i> proteins and adenylyl cycl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of molecular and cellular cardiology 1995, Vol.27 (1), p.357-370
Hauptverfasser: Eschenhagen, Thomas, Diederich, Matthias, Kluge, Sascha H., Magnussen, Olaf, Mene, Ulrike, Müller, Frank, Schmitz, Wilhelm, Scholz, Hasso, Weil, Joachim, Sent, Ulrike, Schaad, Andreas, Scholtysik, Günter, Wüthrich, Andreas, Gaillard, Claude
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 370
container_issue 1
container_start_page 357
container_title Journal of molecular and cellular cardiology
container_volume 27
creator Eschenhagen, Thomas
Diederich, Matthias
Kluge, Sascha H.
Magnussen, Olaf
Mene, Ulrike
Müller, Frank
Schmitz, Wilhelm
Scholz, Hasso
Weil, Joachim
Sent, Ulrike
Schaad, Andreas
Scholtysik, Günter
Wüthrich, Andreas
Gaillard, Claude
description Bovine heriditary cardiomyopathy (bCMP) displays clinical characteristics of human idiopathic dilated cardiomyopathy (DCM). We studied isometric force of contraction in right ventricular trabeculae, plasma and tissue catecholamines, β- and α 1-adrenoceptor density, G i> proteins and adenylyl cyclase activity in eight hearts with bCMP and eight control hearts (right and left atria and ventricles each). Results: Compared to control, the potency of isoprenaline in bCMp was eight-fold decreased, whereas the maximal positive inotropic effect of isoprenaline as well as the efficacy and potency of calcium were unchanged. Plasma moradrenaline was increased by 240%. Tissue noradrenaline and adrenaline were decreased by 36–63% and 58–69%, whereas dopamine was increased by 105–218%. β-adrenoceptor density was drastically reduced by 90%, but binding affinity was unchanged. α-Adrenoceptor density and binding affinity were unchanged. Total PTX-substrates were increased in bCMp by 28–99%. Basal adenylyl cyclase activity was decreased by 36–47%. Similarly, stimulation by GTP, GMPPNP, isoprenaline, sodium fluoride, manganese or forskolin was attenuated by 26–62% (atria) and 45–66% (ventricles). In conclusion, we found marked activation of the sympatho-adrenergic system, downregulation of β-adrenoceptors, upregulation of G i proteins, global desensitization of adenylyl cyclase and selective subsentivity to β-adrenergic inotropic stimulation. These results closely resemble the characteristic alterations in the β-adrenoceptor-G protein-adenylyl cyclase pathway in the human heart failure, indicating that they are general features of heart failure. The similarity to human DCM, the inheritance and the availability of large tissue samples make bCMp asuitable model for human DCM.
doi_str_mv 10.1016/S0022-2828(08)80033-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77294238</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022282808800338</els_id><sourcerecordid>77294238</sourcerecordid><originalsourceid>FETCH-LOGICAL-c360t-bb95fa28e3b15d6e752de47b77128a4eca0272f275e5c4da8c68aa099fc4fa293</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMotVZ_QmFPoofV2WSzyXoRLX5BQUQ9h2wySyO7TU22hf57tx948CIMDMy877zMQ8g4g6sMsuL6HYDSlEoqL0BeSgDGUnlAhhmUPJVc5odk-Cs5JicxfgFAmTM2IAMhCmBcDMnbvV-5OSYzDGhdp8M6MTpY59u1X-hutr5J9Lwv1-omab3FJvF1Mlu2_dS6Rndo_xhOyVGtm4hn-z4in48PH5PndPr69DK5m6aGFdClVVXyWlOJrMq4LVBwajEXlRAZlTpHo4EKWlPBkZvcamkKqTWUZW3y3leyETnf3V0E_73E2KnWRYNNo-fol1EJQcucMtkL-U5ogo8xYK0WoX8nrFUGaoNSbVGqDScFUm1Rqo1vvA9YVi3aX9eeXb-_3e2x_3LlMKhoHM5NzzGg6ZT17p-EH4t8hHk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77294238</pqid></control><display><type>article</type><title>Bovine hereditary cardiomyopathy: an animal model of human dilated cardiomyopathy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Eschenhagen, Thomas ; Diederich, Matthias ; Kluge, Sascha H. ; Magnussen, Olaf ; Mene, Ulrike ; Müller, Frank ; Schmitz, Wilhelm ; Scholz, Hasso ; Weil, Joachim ; Sent, Ulrike ; Schaad, Andreas ; Scholtysik, Günter ; Wüthrich, Andreas ; Gaillard, Claude</creator><creatorcontrib>Eschenhagen, Thomas ; Diederich, Matthias ; Kluge, Sascha H. ; Magnussen, Olaf ; Mene, Ulrike ; Müller, Frank ; Schmitz, Wilhelm ; Scholz, Hasso ; Weil, Joachim ; Sent, Ulrike ; Schaad, Andreas ; Scholtysik, Günter ; Wüthrich, Andreas ; Gaillard, Claude</creatorcontrib><description>Bovine heriditary cardiomyopathy (bCMP) displays clinical characteristics of human idiopathic dilated cardiomyopathy (DCM). We studied isometric force of contraction in right ventricular trabeculae, plasma and tissue catecholamines, β- and α 1-adrenoceptor density, G i&gt; proteins and adenylyl cyclase activity in eight hearts with bCMP and eight control hearts (right and left atria and ventricles each). Results: Compared to control, the potency of isoprenaline in bCMp was eight-fold decreased, whereas the maximal positive inotropic effect of isoprenaline as well as the efficacy and potency of calcium were unchanged. Plasma moradrenaline was increased by 240%. Tissue noradrenaline and adrenaline were decreased by 36–63% and 58–69%, whereas dopamine was increased by 105–218%. β-adrenoceptor density was drastically reduced by 90%, but binding affinity was unchanged. α-Adrenoceptor density and binding affinity were unchanged. Total PTX-substrates were increased in bCMp by 28–99%. Basal adenylyl cyclase activity was decreased by 36–47%. Similarly, stimulation by GTP, GMPPNP, isoprenaline, sodium fluoride, manganese or forskolin was attenuated by 26–62% (atria) and 45–66% (ventricles). In conclusion, we found marked activation of the sympatho-adrenergic system, downregulation of β-adrenoceptors, upregulation of G i proteins, global desensitization of adenylyl cyclase and selective subsentivity to β-adrenergic inotropic stimulation. These results closely resemble the characteristic alterations in the β-adrenoceptor-G protein-adenylyl cyclase pathway in the human heart failure, indicating that they are general features of heart failure. The similarity to human DCM, the inheritance and the availability of large tissue samples make bCMp asuitable model for human DCM.</description><identifier>ISSN: 0022-2828</identifier><identifier>EISSN: 1095-8584</identifier><identifier>DOI: 10.1016/S0022-2828(08)80033-8</identifier><identifier>PMID: 7760357</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adenylate Cyclase Toxin ; Adenylyl Cyclase ; Adenylyl Cyclases - metabolism ; Animals ; Cardiomyopathies - genetics ; Cardiomyopathies - physiopathology ; Cardiomyopathies - veterinary ; Cardiomyopathy, Dilated - physiopathology ; Catecholamines - metabolism ; Catecholomines ; Cattle ; Cattle Diseases ; Colforsin - pharmacology ; Disease Models, Animal ; G-Proteins ; GTP-Binding Proteins - metabolism ; Guanosine Triphosphate - pharmacology ; Guanylyl Imidodiphosphate - pharmacology ; Heart - drug effects ; Heart - physiology ; Heart - physiopathology ; Heart Atria ; Heart Failure ; Heart Ventricles ; Humans ; Isoproterenol - pharmacology ; Manganese - pharmacology ; Myocardial Contraction - drug effects ; Myocardium - metabolism ; Receptors, Adrenergic, alpha-1 - metabolism ; Receptors, Adrenergic, beta - metabolism ; Reference Values ; Sodium Fluoride - pharmacology ; Ventricular Function, Right ; Virulence Factors, Bordetella - metabolism ; α 1-Adrenoceptors ; β 1/β 2-Subtypes ; β-Adrenoceptors</subject><ispartof>Journal of molecular and cellular cardiology, 1995, Vol.27 (1), p.357-370</ispartof><rights>1995 Academic Press Limited</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c360t-bb95fa28e3b15d6e752de47b77128a4eca0272f275e5c4da8c68aa099fc4fa293</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022282808800338$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,4010,27900,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7760357$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Eschenhagen, Thomas</creatorcontrib><creatorcontrib>Diederich, Matthias</creatorcontrib><creatorcontrib>Kluge, Sascha H.</creatorcontrib><creatorcontrib>Magnussen, Olaf</creatorcontrib><creatorcontrib>Mene, Ulrike</creatorcontrib><creatorcontrib>Müller, Frank</creatorcontrib><creatorcontrib>Schmitz, Wilhelm</creatorcontrib><creatorcontrib>Scholz, Hasso</creatorcontrib><creatorcontrib>Weil, Joachim</creatorcontrib><creatorcontrib>Sent, Ulrike</creatorcontrib><creatorcontrib>Schaad, Andreas</creatorcontrib><creatorcontrib>Scholtysik, Günter</creatorcontrib><creatorcontrib>Wüthrich, Andreas</creatorcontrib><creatorcontrib>Gaillard, Claude</creatorcontrib><title>Bovine hereditary cardiomyopathy: an animal model of human dilated cardiomyopathy</title><title>Journal of molecular and cellular cardiology</title><addtitle>J Mol Cell Cardiol</addtitle><description>Bovine heriditary cardiomyopathy (bCMP) displays clinical characteristics of human idiopathic dilated cardiomyopathy (DCM). We studied isometric force of contraction in right ventricular trabeculae, plasma and tissue catecholamines, β- and α 1-adrenoceptor density, G i&gt; proteins and adenylyl cyclase activity in eight hearts with bCMP and eight control hearts (right and left atria and ventricles each). Results: Compared to control, the potency of isoprenaline in bCMp was eight-fold decreased, whereas the maximal positive inotropic effect of isoprenaline as well as the efficacy and potency of calcium were unchanged. Plasma moradrenaline was increased by 240%. Tissue noradrenaline and adrenaline were decreased by 36–63% and 58–69%, whereas dopamine was increased by 105–218%. β-adrenoceptor density was drastically reduced by 90%, but binding affinity was unchanged. α-Adrenoceptor density and binding affinity were unchanged. Total PTX-substrates were increased in bCMp by 28–99%. Basal adenylyl cyclase activity was decreased by 36–47%. Similarly, stimulation by GTP, GMPPNP, isoprenaline, sodium fluoride, manganese or forskolin was attenuated by 26–62% (atria) and 45–66% (ventricles). In conclusion, we found marked activation of the sympatho-adrenergic system, downregulation of β-adrenoceptors, upregulation of G i proteins, global desensitization of adenylyl cyclase and selective subsentivity to β-adrenergic inotropic stimulation. These results closely resemble the characteristic alterations in the β-adrenoceptor-G protein-adenylyl cyclase pathway in the human heart failure, indicating that they are general features of heart failure. The similarity to human DCM, the inheritance and the availability of large tissue samples make bCMp asuitable model for human DCM.</description><subject>Adenylate Cyclase Toxin</subject><subject>Adenylyl Cyclase</subject><subject>Adenylyl Cyclases - metabolism</subject><subject>Animals</subject><subject>Cardiomyopathies - genetics</subject><subject>Cardiomyopathies - physiopathology</subject><subject>Cardiomyopathies - veterinary</subject><subject>Cardiomyopathy, Dilated - physiopathology</subject><subject>Catecholamines - metabolism</subject><subject>Catecholomines</subject><subject>Cattle</subject><subject>Cattle Diseases</subject><subject>Colforsin - pharmacology</subject><subject>Disease Models, Animal</subject><subject>G-Proteins</subject><subject>GTP-Binding Proteins - metabolism</subject><subject>Guanosine Triphosphate - pharmacology</subject><subject>Guanylyl Imidodiphosphate - pharmacology</subject><subject>Heart - drug effects</subject><subject>Heart - physiology</subject><subject>Heart - physiopathology</subject><subject>Heart Atria</subject><subject>Heart Failure</subject><subject>Heart Ventricles</subject><subject>Humans</subject><subject>Isoproterenol - pharmacology</subject><subject>Manganese - pharmacology</subject><subject>Myocardial Contraction - drug effects</subject><subject>Myocardium - metabolism</subject><subject>Receptors, Adrenergic, alpha-1 - metabolism</subject><subject>Receptors, Adrenergic, beta - metabolism</subject><subject>Reference Values</subject><subject>Sodium Fluoride - pharmacology</subject><subject>Ventricular Function, Right</subject><subject>Virulence Factors, Bordetella - metabolism</subject><subject>α 1-Adrenoceptors</subject><subject>β 1/β 2-Subtypes</subject><subject>β-Adrenoceptors</subject><issn>0022-2828</issn><issn>1095-8584</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LAzEQhoMotVZ_QmFPoofV2WSzyXoRLX5BQUQ9h2wySyO7TU22hf57tx948CIMDMy877zMQ8g4g6sMsuL6HYDSlEoqL0BeSgDGUnlAhhmUPJVc5odk-Cs5JicxfgFAmTM2IAMhCmBcDMnbvV-5OSYzDGhdp8M6MTpY59u1X-hutr5J9Lwv1-omab3FJvF1Mlu2_dS6Rndo_xhOyVGtm4hn-z4in48PH5PndPr69DK5m6aGFdClVVXyWlOJrMq4LVBwajEXlRAZlTpHo4EKWlPBkZvcamkKqTWUZW3y3leyETnf3V0E_73E2KnWRYNNo-fol1EJQcucMtkL-U5ogo8xYK0WoX8nrFUGaoNSbVGqDScFUm1Rqo1vvA9YVi3aX9eeXb-_3e2x_3LlMKhoHM5NzzGg6ZT17p-EH4t8hHk</recordid><startdate>1995</startdate><enddate>1995</enddate><creator>Eschenhagen, Thomas</creator><creator>Diederich, Matthias</creator><creator>Kluge, Sascha H.</creator><creator>Magnussen, Olaf</creator><creator>Mene, Ulrike</creator><creator>Müller, Frank</creator><creator>Schmitz, Wilhelm</creator><creator>Scholz, Hasso</creator><creator>Weil, Joachim</creator><creator>Sent, Ulrike</creator><creator>Schaad, Andreas</creator><creator>Scholtysik, Günter</creator><creator>Wüthrich, Andreas</creator><creator>Gaillard, Claude</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1995</creationdate><title>Bovine hereditary cardiomyopathy: an animal model of human dilated cardiomyopathy</title><author>Eschenhagen, Thomas ; Diederich, Matthias ; Kluge, Sascha H. ; Magnussen, Olaf ; Mene, Ulrike ; Müller, Frank ; Schmitz, Wilhelm ; Scholz, Hasso ; Weil, Joachim ; Sent, Ulrike ; Schaad, Andreas ; Scholtysik, Günter ; Wüthrich, Andreas ; Gaillard, Claude</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c360t-bb95fa28e3b15d6e752de47b77128a4eca0272f275e5c4da8c68aa099fc4fa293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adenylate Cyclase Toxin</topic><topic>Adenylyl Cyclase</topic><topic>Adenylyl Cyclases - metabolism</topic><topic>Animals</topic><topic>Cardiomyopathies - genetics</topic><topic>Cardiomyopathies - physiopathology</topic><topic>Cardiomyopathies - veterinary</topic><topic>Cardiomyopathy, Dilated - physiopathology</topic><topic>Catecholamines - metabolism</topic><topic>Catecholomines</topic><topic>Cattle</topic><topic>Cattle Diseases</topic><topic>Colforsin - pharmacology</topic><topic>Disease Models, Animal</topic><topic>G-Proteins</topic><topic>GTP-Binding Proteins - metabolism</topic><topic>Guanosine Triphosphate - pharmacology</topic><topic>Guanylyl Imidodiphosphate - pharmacology</topic><topic>Heart - drug effects</topic><topic>Heart - physiology</topic><topic>Heart - physiopathology</topic><topic>Heart Atria</topic><topic>Heart Failure</topic><topic>Heart Ventricles</topic><topic>Humans</topic><topic>Isoproterenol - pharmacology</topic><topic>Manganese - pharmacology</topic><topic>Myocardial Contraction - drug effects</topic><topic>Myocardium - metabolism</topic><topic>Receptors, Adrenergic, alpha-1 - metabolism</topic><topic>Receptors, Adrenergic, beta - metabolism</topic><topic>Reference Values</topic><topic>Sodium Fluoride - pharmacology</topic><topic>Ventricular Function, Right</topic><topic>Virulence Factors, Bordetella - metabolism</topic><topic>α 1-Adrenoceptors</topic><topic>β 1/β 2-Subtypes</topic><topic>β-Adrenoceptors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eschenhagen, Thomas</creatorcontrib><creatorcontrib>Diederich, Matthias</creatorcontrib><creatorcontrib>Kluge, Sascha H.</creatorcontrib><creatorcontrib>Magnussen, Olaf</creatorcontrib><creatorcontrib>Mene, Ulrike</creatorcontrib><creatorcontrib>Müller, Frank</creatorcontrib><creatorcontrib>Schmitz, Wilhelm</creatorcontrib><creatorcontrib>Scholz, Hasso</creatorcontrib><creatorcontrib>Weil, Joachim</creatorcontrib><creatorcontrib>Sent, Ulrike</creatorcontrib><creatorcontrib>Schaad, Andreas</creatorcontrib><creatorcontrib>Scholtysik, Günter</creatorcontrib><creatorcontrib>Wüthrich, Andreas</creatorcontrib><creatorcontrib>Gaillard, Claude</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of molecular and cellular cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eschenhagen, Thomas</au><au>Diederich, Matthias</au><au>Kluge, Sascha H.</au><au>Magnussen, Olaf</au><au>Mene, Ulrike</au><au>Müller, Frank</au><au>Schmitz, Wilhelm</au><au>Scholz, Hasso</au><au>Weil, Joachim</au><au>Sent, Ulrike</au><au>Schaad, Andreas</au><au>Scholtysik, Günter</au><au>Wüthrich, Andreas</au><au>Gaillard, Claude</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bovine hereditary cardiomyopathy: an animal model of human dilated cardiomyopathy</atitle><jtitle>Journal of molecular and cellular cardiology</jtitle><addtitle>J Mol Cell Cardiol</addtitle><date>1995</date><risdate>1995</risdate><volume>27</volume><issue>1</issue><spage>357</spage><epage>370</epage><pages>357-370</pages><issn>0022-2828</issn><eissn>1095-8584</eissn><abstract>Bovine heriditary cardiomyopathy (bCMP) displays clinical characteristics of human idiopathic dilated cardiomyopathy (DCM). We studied isometric force of contraction in right ventricular trabeculae, plasma and tissue catecholamines, β- and α 1-adrenoceptor density, G i&gt; proteins and adenylyl cyclase activity in eight hearts with bCMP and eight control hearts (right and left atria and ventricles each). Results: Compared to control, the potency of isoprenaline in bCMp was eight-fold decreased, whereas the maximal positive inotropic effect of isoprenaline as well as the efficacy and potency of calcium were unchanged. Plasma moradrenaline was increased by 240%. Tissue noradrenaline and adrenaline were decreased by 36–63% and 58–69%, whereas dopamine was increased by 105–218%. β-adrenoceptor density was drastically reduced by 90%, but binding affinity was unchanged. α-Adrenoceptor density and binding affinity were unchanged. Total PTX-substrates were increased in bCMp by 28–99%. Basal adenylyl cyclase activity was decreased by 36–47%. Similarly, stimulation by GTP, GMPPNP, isoprenaline, sodium fluoride, manganese or forskolin was attenuated by 26–62% (atria) and 45–66% (ventricles). In conclusion, we found marked activation of the sympatho-adrenergic system, downregulation of β-adrenoceptors, upregulation of G i proteins, global desensitization of adenylyl cyclase and selective subsentivity to β-adrenergic inotropic stimulation. These results closely resemble the characteristic alterations in the β-adrenoceptor-G protein-adenylyl cyclase pathway in the human heart failure, indicating that they are general features of heart failure. The similarity to human DCM, the inheritance and the availability of large tissue samples make bCMp asuitable model for human DCM.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>7760357</pmid><doi>10.1016/S0022-2828(08)80033-8</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2828
ispartof Journal of molecular and cellular cardiology, 1995, Vol.27 (1), p.357-370
issn 0022-2828
1095-8584
language eng
recordid cdi_proquest_miscellaneous_77294238
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adenylate Cyclase Toxin
Adenylyl Cyclase
Adenylyl Cyclases - metabolism
Animals
Cardiomyopathies - genetics
Cardiomyopathies - physiopathology
Cardiomyopathies - veterinary
Cardiomyopathy, Dilated - physiopathology
Catecholamines - metabolism
Catecholomines
Cattle
Cattle Diseases
Colforsin - pharmacology
Disease Models, Animal
G-Proteins
GTP-Binding Proteins - metabolism
Guanosine Triphosphate - pharmacology
Guanylyl Imidodiphosphate - pharmacology
Heart - drug effects
Heart - physiology
Heart - physiopathology
Heart Atria
Heart Failure
Heart Ventricles
Humans
Isoproterenol - pharmacology
Manganese - pharmacology
Myocardial Contraction - drug effects
Myocardium - metabolism
Receptors, Adrenergic, alpha-1 - metabolism
Receptors, Adrenergic, beta - metabolism
Reference Values
Sodium Fluoride - pharmacology
Ventricular Function, Right
Virulence Factors, Bordetella - metabolism
α 1-Adrenoceptors
β 1/β 2-Subtypes
β-Adrenoceptors
title Bovine hereditary cardiomyopathy: an animal model of human dilated cardiomyopathy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T07%3A51%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bovine%20hereditary%20cardiomyopathy:%20an%20animal%20model%20of%20human%20dilated%20cardiomyopathy&rft.jtitle=Journal%20of%20molecular%20and%20cellular%20cardiology&rft.au=Eschenhagen,%20Thomas&rft.date=1995&rft.volume=27&rft.issue=1&rft.spage=357&rft.epage=370&rft.pages=357-370&rft.issn=0022-2828&rft.eissn=1095-8584&rft_id=info:doi/10.1016/S0022-2828(08)80033-8&rft_dat=%3Cproquest_cross%3E77294238%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77294238&rft_id=info:pmid/7760357&rft_els_id=S0022282808800338&rfr_iscdi=true